Pfizer raises COVID-19 vaccine sales forecast

Pfizer raises COVID-19 vaccine sales forecast

By Excelsio Media on November 02, 2021 Also in covid-19, economy, Pfizer

Pfizer said it expected 2021 sales of the COVID-19 vaccine it developed with German partner BioNTech to reach $36 billion and forecast another $29 billion from the shot in 2022, topping analyst estimates for both years.

Comments

Comentarios de Facebook

Subscribe to: Post Comments (Atom)